Morgan Ventures
Fundamental Score
Morgan Ventures Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of 526237 across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (32.03%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (18.33%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (94.29%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 3.21 vs Industry: 22.03)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Consistent Growth Track Record (108.14% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (200.98% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (200.98% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (74.80%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Elevated Debt Levels (D/E: 1.85)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-8.79 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Morgan Ventures
About 526237
Company Details
526237 Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Morgan Ventures (526237)?
As of 30 Sept 2025, 03:25 pm IST, Morgan Ventures (526237) is currently trading at ₹74.40. The stock has a market capitalization of ₹73.66 (Cr).
Is 526237 share price Overvalued or Undervalued?
526237 is currently trading at a P/E ratio of 3.21x, compared to the industry average of 22.03x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Morgan Ventures share price?
Key factors influencing 526237's price include its quarterly earnings growth (Sales Growth: 11.24%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Morgan Ventures a good stock for long-term investment?
Morgan Ventures shows a 5-year Profit Growth of 200.98% and an ROE of 32.03%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.85 before investing.
How does Morgan Ventures compare with its industry peers?
Morgan Ventures competes with major peers in the Non Banking Financial Company (NBFC). Investors should compare 526237's P/E of 3.21x and ROE of 32.03% against the industry averages to determine its competitive standing.
What is the P/E ratio of 526237 and what does it mean?
526237 has a P/E ratio of 3.21x compared to the industry average of 22.03x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹3 for every ₹1 of annual earnings.
How is 526237 performing according to Bull Run's analysis?
526237 has a Bull Run fundamental score of 60.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does 526237 belong to?
526237 operates in the Non Banking Financial Company (NBFC) industry. This classification helps understand the competitive landscape and sector-specific trends affecting Morgan Ventures.
What is Return on Equity (ROE) and why is it important for 526237?
526237 has an ROE of 32.03%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Morgan Ventures generates profits from shareholders' equity.
How is 526237's debt-to-equity ratio and what does it indicate?
526237 has a debt-to-equity ratio of 1.85, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is 526237's dividend yield and is it a good dividend stock?
526237 offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has 526237 grown over the past 5 years?
526237 has achieved 5-year growth rates of: Sales Growth 108.14%, Profit Growth 200.98%, and EPS Growth 200.98%.
What is the promoter holding in 526237 and why does it matter?
Promoters hold 74.80% of 526237 shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is 526237's market capitalization category?
526237 has a market capitalization of ₹74 crores, placing it in the Small-cap category.
How volatile is 526237 stock?
526237 has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for 526237?
526237 has a 52-week high of ₹N/A and low of ₹N/A.
What is 526237's operating profit margin trend?
526237 has a 5-year average Operating Profit Margin (OPM) of 94.29%, indicating the company's operational efficiency.
How is 526237's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 11.24% and YoY Profit Growth of 7.45%.
What is the institutional holding pattern in 526237?
526237 has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.